Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase-2 (COX-2) expression

International Journal of Cancer

Volumn 111, Issue 3, 2004, Pages 322-331

  Han, Shouwei ^a   Sidell, Neil ^a   Roser Page, Susanne ^a   Roman, Jesse ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C EBP; CAMP response element; COX 2; Fibronectin; Human lung carcinoma cells; NF IL6

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALPHOSTIN C; CCAAT ENHANCER BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; DNA; FIBRONECTIN; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; PROTEIN KINASE C INHIBITOR; VERY LATE ACTIVATION ANTIGEN 5;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONNECTIVE TISSUE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS; PROTEIN BINDING; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; UPREGULATION; WILD TYPE;

APOPTOSIS; BASE SEQUENCE; CARCINOMA, SMALL CELL; CELL ADHESION; CELL DIVISION; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; DNA PRIMERS; DNA REPLICATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MEMBRANE PROTEINS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 3242882629     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20281     Document Type: Article

References (54)

1. Ramanathan R, Belani C. Chemotherapy for advanced non-small cell lung carcinoma: past, present, and future. Semin Oncol 1997;24:440-54.
2. Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JD. Etiology and epidemiology of lung cancer. In: Schottenfeld D, ed. Lung cancer. Philadelphia: Lippincott Williams and Wilkins, 2000. 367-88.
3. Vial WC. Cigarette smoking and lung disease. Am J Med Sci 1986;291:130-42.
4. Oyama F, Hirohashi S, Shimasato Y, Titani K, Sekiguchi K. Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin. Cancer Res 1991;51:4876-81.
5. Michaelson JE, Ritzenthaler JD, Roman J. Regulation of serum-induced fibronectin expression by protein kinases, cytoskeletal integrity, and CREB. Am J Physiol Lung Cell Mol Physiol 2002;282: L291-301.
6. Labat-Robert J. Fibronectin in malignancy. Semin Cancer Biol 2002;12:187-95.
7. Cress TM, Muller-Pillasch F, Lerch MM, Friess H, Buchler M, Adler G. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic carcinoma. Int J Cancer 1995;62:407-13.
8. Zhang GJ, Ladehoff D, Xu Y, See WA. Stable overexpression of TGFbeta1 in a transitional carcinoma cell line: impact on fibronectin production. J Urol 1998;160:230-5.
9. Jiang Y, Harlocker SL, Molesh DA, Dillon DC, Stolk JA, Houghton RL, Repasky EA, Badaro R, Reed SG, Xu J. Discovery of differentially expressed genes in human breast carcinoma using subtracted cDNA libraries and cDNA microarrays. Oncogene 2002;21:2270-82.
10. Nanki N, Fujita J, Yang Y, Hojo S, Bandoh S, Yamaji Y, Ishida T. Expression of oncofetal fibronectin and syndecan-1 mRNA in 18 human lung carcinoma cell lines. Tumor Biol 2001;22:390-6.
11. Jakowlew SB, Mariano JM, You L, Mathias A. Differential regulation of protease and extracellular matrix protein expression by transforming growth factor-beta 1 in non-small cell lung carcinoma cells and normal human bronchial epithelial cells. Biochim Biophys Acta 1997;1353:157-70.
12. Rintoul RC, Sethi T. Extracellular matrix regulation of drug resistance in small-cell lung carcinoma. Clin Sci (Lond) 2002;102:417-24.
13. Boles BK, Ritzenthaler J, Birkenmeier T, Roman J. Phorbol ester-induced U-937 differentiation: effects on integrin alpha (5) gene transcription. Am J Physiol Lung Cell Mol Physiol 2000;278:L703-12.
14. Akiyama SK, Yamada SS, Chen WT, Yamada KM. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J CeIl Biol 1989;109:863-75.
15. Saito T, Kimura M, Kawasaki T, Sato S, Tomita Y. Correlation between integrin alpha 5 expression and the malignant phenotype of transitional cell carcinoma. Br J Cancer 1996;73:327-31.
16. Adachi M, Taki T, Higashiyama M, Kohno N, Inufusa H, Miyake M. Significance of integrin alpha5 gene expression as a prognostic factor in node-negative non-small cell lung carcinoma. Clin Cancer Res 2000;6:96-101.
17. Lin DT, Subbaramaiah K, Shah JP, Dannenberg AJ, Boyle JO. Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck carcinoma. Head Neck 2002;24:792-9.
18. Joo YE, Kim HS, Min SW, Lee WS, Park CH, Park CS, Choi SK, Rew JS, Kim SJ. Expression of cyclooxygenase-2 protein in colorectal carcinomas. Int J Gastrointest Cancer 2002;31:147-54.
19. Dempke W, Rie C, Grothey A, Schmoll HJ. Cyclooxygenase-2: a novel target for carcinoma chemotherapy? J Cancer Res Clin Oncol 2001;127:411-7.
20. Fossilen E. Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci 2000;37:431-502.
21. Dohadwala M, Luo J, Zhu L, Lin Y, Dougherty GJ, Sharma S, Huang M, Pold M, Batra RK, Dubinett SM. Non-small cell lung carcinoma cyclooxygenase-2- dependent invasion is mediated by CD44. J Biol Chem 2001;276:20809-12.
22. Pyo H, Choy H. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin Cancer Res 2001;7:2998-3005.
23. Parker J, Kaplon MK, Alvarez CJ, Krishnaswamy G. Prostaglandin H synthase expression is variable in human colorectal adenocarcinoma cell lines. Exp Cell Res 1997;236:321-9.
24. Cheng HF, Wang CJ, Moeckel GW, Zhang MZ, McKanna JA, Harris RC. Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension. Kidney Int 2002;62:929-39.
25. Han S, Sidell N. RU486-induced growth inhibition of human endometrial cells involves the nuclear factor-kappaB signaling pathway. J Clin Endocrinol Metab 2003;88:713-9.
26. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994;47:55-9.
27. Han S, Sidell N. Peroxisome-proliferator-activated-receptor gamma (PPARgamma) independent induction of CD36 in THP-1 monocytes by retinoic acid. Immunology 2002;106:53-9.
28. Abassi Z, Brodsky S, Gealekman O, Rubinstein I, Hoffman A, Winaver J. Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure. Am J Physiol Renal Physiol 2001;280:F43-53.
29. Han SW, Lei ZM, Rao CV. Up-regulation of cyclooxygenase-2 gene expression by chorionic gonadotropin during the differentiation of human endometrial stromal cells into decidua. Endocrinology 1996;137:1791-7.
30. Inoue H, Umesono K, Nishimori T, Hirata Y, Tanabe T. Glucocorticoid- mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells. Biochem Biophys Res Commun 1999;254:292-8.
31. Han S, Wada RK, Sidell N. Differentiation of human neuroblastoma by phenylacetate is mediated by peroxisome proliferator-activated receptor gamma. Cancer Res 2001;61:3998-4002.
32. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acids Res 1983;11:1475-89.
33. Schroer K, Zhu Y, Saunders MA, Deng WG, Xu XM, Meyer-Kirchrath J, Wu KK. Obligatory role of cyclic adenosine monophosphate response element in cyclooxygenase-2 promoter induction and feedback regulation by inflammatory mediators. Circulation 2002;105:2760-5.
34. Saunders MA, Sansores-Garcia L, Gilroy DW, Wu KK. Selective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblasts. J Biol Chem 2001;276:18897-904.
35. Larouche K, Leclerc S, Salesse C, Guerin SL. Expression of the alpha 5 integrin subunit gene promoter is positively regulated by the extra-cellular matrix component fibronectin through the transcription factor Sp1 in corneal epithelial cells in vitro. J Biol Chem 2000;275:39182-92.
36. Roman J, Ritzenthaler JD, Fenton MJ, Roser S, Schuyler W. Transcriptional regulation of the human interleukin 1beta gene by fibronectin: role of protein kinase C and activator protein 1 (AP-1). Cytokine 2000;12:1581-96.
37. Defilippi P, Venturino M, Gulino D, Duperray A, Boquet P, Fiorentini C, Volpe G, Palmieri M, Silengo L, Tarone G. Dissection of pathways implicated in integrin-mediated actin cytoskeleton assembly: involvement of protein kinase C, Rho GTPase, and tyrosine phosphorylation. J Biol Chem 1997;272:21726-34.
38. Wilson SH, Ljubimov AV, Morla AO, Caballero S, Shaw LC, Spoerri PE, Tarnuzzer RW, Grant MB. Fibronectin fragments promote human retinal endothelial cell adhesion and proliferation and ERK activation through alpha5beta1 integrin and PI 3-kinase. Invest Ophthalmol Vis Sci 2003;44:1704-15.
39. Howe LR, Subbaramaiah K, Brown AM, Dannenberg AJ. Cyclooxygenase-2: a target for the prevention and treatment of breast carcinoma. Endocr Relat Cancer 2001;8:97-114.
40. Gorgoni B, Caivano M, Arizmendi C, Poli V. The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts. J Biol Chem 2001;276:40769-77.
41. Leskinen MJ, Lindstedt KA, Wang Y, Kovanen PT. Mast cell chymase induces smooth muscle cell apoptosis by a mechanism involving fibronectin degradation and disruption of focal adhesions. Arterioscler Thromb Vasc Biol 2003;23:238-43.
42. Illario M, Amideo V, Casamassima A, Andreucci M, di Matola T, Miele C, Rossi G, Fenzi G, Vitale M. Integrin-dependent cell growth and survival are mediated by different signals in thyroid cells. J Clin Endocrinol Metab 2003;88:260-9.
43. Katori M, Majima M. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res 2000;49:367-92.
44. Kirtikara K, Raghow R, Laulederkind SJ, Goorha S, Kanekura T, Ballou LR. Transcriptional regulation of cyclooxygenase-2 in the human microvascular endothelial cell line, HMEC-1: control by the combinatorial actions of AP2, NF-IL-6 and CRE elements. Mol Cell Biochem 2000;203:41-51.
45. Liu XH, Kirschenbaum A, Lu M, Yao S, Klausner A, Preston C, Holland JF, Levine AC. Prostaglandin E(2) stimulates prostatic intra-epithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. Biochem Biophys Res Commun 2002;290:249-55.
46. Danen EH, Yamada KM. Fibronectin, integrins, and growth control. J Cell Physiol 2001;189:1-13.
47. Chen CC, Sun YT, Chen JJ, Chang YJ. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells. Mol Pharmacol 2001;59:493-500.
48. Nagano S, Otsuka T, Niiro H, Yamaoka K, Arinobu Y, Ogami E, Akahoshi M, Inoue Y, Miyake K, Nakashima H, Niho Y, Harada M. Molecular mechanisms of lipopolysaccharide-induced cyclooxygenase-2 expression in human neutrophils: involvement of the mitogen-activated protein kinase pathway and regulation by anti-inflammatory cytokines. Int Immunol 2002;14:733-40.
49. Mifflin RC, Saada JI, Di Mari JF, Adegboyega PA, Valentich JD, Powell DW. Regulation of COX-2 expression in human intestinal myofibroblasts: mechanisms of IL-1-mediated induction. Am J Physiol Cell Physiol 2002;282:C824-34.
50. Eliopoulos AG, Dumitru CD, Wang CC, Cho J, Tsichlis PN. Induction of COX-2 by LPS in macrophages is regulated by Tp12-dependent CREB activation signals. EMBO J 2002;21:4831-40.
51. Shao J, Sheng H, Inoue H, Morrow JD, DuBois RN. Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J Biol Chem 2000;275:33951-6.
52. Wadleigh DJ, Herschman HR. Transcriptional regulation of the cyclooxygenase-2 gene by diverse ligands in murine osteoblasts. Biochem Biophys Res Commun 1999;264:865-70.
53. Kim Y, Fischer SM. Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells: regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J Biol Chem 1998;273:27686-94.
54. Wardlaw SA, Zhang N, Belinsky SA. Transcriptional regulation of basal cyclooxygenase-2 expression in murine lung tumor-derived cell lines by CCAAT/enhancer-binding protein and activating transcription factor/cAMP response element-binding protein. Mol Pharmacol 2002;62:326-33.